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while the intimal lesions, frequently limited on the posterior wall,
play a minor role.
In our opinion, a transverse arteriotomy at the level of the
Angio-Seal introduction site could lead to a safe removal of the
anchorage system, permitting a sufficient exploration of the poste-
rior intimal layer. We retain that this has been the surgical approach
on patient 3 in this report. Moreover, in the case of a posterior
intimal defect, a limited resection of the flap and a Kunlin suture
can be performed easily. This approach is preferable, in our opin-
ion, allowing the avoidance of a longitudinal arteriotomy and
usage of a prosthetic patch for the arterial reconstruction. In our
experience, the longitudinal arteriotomy can be reserved only
where there is an extensive intimal lesion, previously demonstrated
by a transverse arteriotomy or in cases of diffuse atherosclerotic
involvement of the common femoral artery.
Moreover, if longitudinal arteriotomy is the only option, we
suggest the use of an autologous saphenous vein patch to decrease
the possibility of infection as demonstrated by Gonzo et al.3-5
In conclusion, we believe the ischemic complication of the
Angio-Seal device should be approached by a transverse arteriot-
omy, without the use of prosthetic material. An eventual autolo-
gous vein patch is the preferred material when an arterial recon-
struction is needed.
Andrea Siani, MD
Luca Maria Siani, MD
Giustino Marcucci, MD
Francesco Mounayergi, MD
Department of Vascular Surgery
“S. Paolo” Hospital
Civitavecchia, Rome, Italy
Emanuele Baldassarre, MD
Department of Urology
Regional Hospital
Aosta, Italy
REFERENCES
1. Dregelid E, Jensen G, Daryapeyma A. Complications associated with the
Angio-Seal arterial puncture closing device: intra-arterial deployment
and occlusion by dissected plaque. J Vasc Surg 2006;44:1357-9.
2. Siani A, Zaccaria A, Schioppa A, Flaishman I. Management of acute lower
limb ischemia following percutaneous arterial closure device application:
our experience. G Chir 2006;27:119-22.
3. Cooper CL, Miller A. Infectious complications related to the use of the
Angio-Seal hemostatic puncture closure device. Catheter Cardiovasc
Interv 1999;48:301-3.
4. Whitton Holis H, Jr, Rehring TF. Femoral endarteritis associated with
percutaneous suture closure: new technology, challenging complica-
tions. J Vasc Surg 2003;38:83-7.
5. Gonze MD, Sternbergh WC III, Salartash K, Money SR. Complications
associated with percutaneous closure devices. Am J Surg 1999;178:
209-11.
doi:10.1016/j.jvs.2007.03.057
Reply
There is no scientific evidence to prefer either the transverse or
longitudinal arteriotomy for removal of endoluminally displaced
Angio-Seal sponges. We elected to use longitudinal arteriotomies
in all four patients who were the subjects of our report because
longitudinal arteriotomy provides better intraluminal exposure. In
three of the patients, the arteriotomy was closed without patch
insertion. Intraluminal displacement of Angio-Seal sponges often
is due to plaque. A longitudinal arteriotomy provides better expo-
sure and allows a more controlled removal of a plaque that pro-
trudes or that is partially avulsed due to interference with the
Angio-Seal device.
Although closure of longitudinal arteriotomy may produce
stenosis, which may be prevented by closure with a patch, it has
been shown experimentally that it is possible to close longitudinal
arteriotomies without creating significant stenosis even in thin rat
femoral arteries.1 In our experience, longitudinal arteriotomies
usually can be closed without creating a stenosis and without the
necessity of using a patch provided small bites are taken with the
suture and provided the suture is not tightened unnecessarily.
Whenever possible, it is desirable to avoid using prosthetic
material when an arteriotomy is being closed, and particularly in
the groin, because of the risk of infection and the prosthetic
material’s tendency to provoke foreign body reaction and throm-
bus formation. In the groin, a minor stenosis due to direct closure
without a patch may be preferable to patch closure due to the risk
of infection. When a patch has to be used, a vein patch is preferable
to a prosthetic patch,2-4 and it should not be so wide as to cause a
marked increase in luminal diameter at the arteriotomy site since a
localized arterial widening can cause turbulence and mural throm-
bus formation.5
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Regarding “Perioperative Use of Statins Does not
Reduce Cardiovascular Risk”
In the article by Schouten et al,1 the authors included the
review of several recent studies that addressed the beneficial effect
of statin use in patients undergoing “major vascular, noncardiac
surgery.”
Soon after the publication of the article by Schouten et al
(August 2006),1 a systematic review by Kapoor et al2 to determine
the strength of evidence for using statins during the perioperative
period to reduce the risk of cardiovascular events was pub-
lished (November 2006). Owing to methodological heterogeneity
among studies, they carried out a meta-analysis of methodologi-
cally similar studies (eg, all randomized trials or all cohort studies).
Regarding perioperative death or acute coronary syndrome, pool-
ing the data from all 13 cohort studies gave a summary odds ratio
(OR) of 0.70 (95% confidence interval [CI], 0.57 to 0.87) with
statin use (1, favors statin use; 1, favors control). Certainly,
these 13 studies were methodologically similar because of all
cohorts. Obvious between-study heterogeneity concerning types
of surgery, however, was present in the pooled estimate derived
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